Tacrolimus: A cause of hypertrophic cardiomyopathy in pediatric heart transplant recipients?

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 82-83

  Scott, J S ^a   Boyle, G J ^a   Daubeney, P E ^a   Miller, S A ^a   Law, Y ^a   Pigula, F ^a   Griffith, B P ^a   Webber, S A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; TACROLIMUS;

CHILD; CONFERENCE PAPER; CONTROLLED STUDY; DRUG INDUCED DISEASE; GRAFT REJECTION; HEART LEFT VENTRICLE MASS; HEART TRANSPLANTATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; PEDIATRIC SURGERY; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY;

CARDIOMYOPATHY, HYPERTROPHIC; CHILD; CYCLOSPORINE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TACROLIMUS; TIME FACTORS;

EID: 0033033107     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01447-X     Document Type: Conference Paper

References (4)

1. Atkison P., Joubert G., Barron A., et al. Lancet. 345:1995;894.
2. Devereux R.B., Alonso D.R., Lutas E.M., et al. Am J Cardiol. 57:1986;450.
3. Skelton R., Gill A.B., Parsons J.M. Arch Dis Child Fetal Neonatal. 78:1998;F133.
4. Park S.C., Beerman L.B., Gartner J.C., et al. Am J Cardiol. 55:1985;1373.